Jack Nathan Medical Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Jack Nathan Medical's earnings have been declining at an average annual rate of -9.7%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 34.1% per year.
Belangrijke informatie
-9.7%
Groei van de winst
2.6%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | -6.7% |
| Inkomstengroei | 34.1% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -40.7% |
| Laatste winstupdate | 31 Jul 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%
Aug 12
Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%
Jun 28Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story
Feb 07Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)
Oct 27Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings
Dec 31Opbrengsten en kosten
Hoe Jack Nathan Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Jul 24 | 21 | -9 | 22 | 0 |
| 30 Apr 24 | 20 | -8 | 20 | 0 |
| 31 Jan 24 | 19 | -7 | 18 | 0 |
| 31 Oct 23 | 17 | -8 | 17 | 0 |
| 31 Jul 23 | 17 | -7 | 16 | 0 |
| 30 Apr 23 | 16 | -6 | 16 | 0 |
| 31 Jan 23 | 15 | -7 | 17 | 0 |
| 31 Oct 22 | 16 | -6 | 16 | 0 |
| 31 Jul 22 | 14 | -7 | 15 | 0 |
| 30 Apr 22 | 12 | -8 | 14 | 0 |
| 31 Jan 22 | 10 | -8 | 12 | 1 |
| 31 Oct 21 | 6 | -7 | 9 | 1 |
| 31 Jul 21 | 5 | -14 | 7 | 0 |
| 30 Apr 21 | 4 | -11 | 5 | 0 |
| 31 Jan 21 | 4 | -10 | 4 | 0 |
| 31 Oct 20 | 4 | -9 | 3 | 0 |
| 31 Jul 20 | 4 | 0 | 2 | 0 |
| 30 Apr 20 | 4 | -2 | 2 | 0 |
| 31 Jan 20 | 4 | -1 | 3 | 0 |
| 31 Jan 19 | 3 | 2 | 1 | 0 |
Kwaliteitswinsten: JNH is currently unprofitable.
Groeiende winstmarge: JNH is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: JNH is unprofitable, and losses have increased over the past 5 years at a rate of 9.7% per year.
Versnelling van de groei: Unable to compare JNH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: JNH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement op eigen vermogen
Hoge ROE: JNH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.